FDA expands Wegovy’s indication to reduce cardiovascular risks in overweight or obesity adults
The approval was based on Wegovy's efficacy and safety results from the SELECT cardiovascular outcomes study in which…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Mar 24
The approval was based on Wegovy's efficacy and safety results from the SELECT cardiovascular outcomes study in which…
11 Mar 24
The platform will consolidate administrative functions, facilitating better control and management for healthcare facilities.
08 Mar 24
The approval was based on the overall response rate (ORR) from the ROSEWOOD study in which ORR was…
07 Mar 24
The investment, announced by the UK government as part of Finance Minister Jeremy Hunt's spring budget, is expected…
06 Mar 24
Diasorin (FTSE MIB: DIA) announced today that it has received 510(k) clearance from the U.S. Food and Drug…
06 Mar 24
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from three real-world retrospective studies being presented at the…
06 Mar 24
March 4th 2024 marks the 7th International HPV Awareness Day, a global campaign proposed by the International Papillomavirus…
04 Mar 24
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products,…
29 Feb 24
The FDA has set a PDUFA target action date of 28 August 2024 for the investigational, Aldose Reductase…
29 Feb 24
Greenway Patient Connect aims to support three daily elements of a patient’s experience - access, communication, and readiness.